EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Buprenorphine and Buprenorphine/Naloxone Diversion, Misuse, and Illicit Use: An International Review

Michael A Yokell, Nickolas D Zaller, Traci C Green, Josiah D Rich

Current Drug Abuse Reviewse · 01.03.2011 · 4 (1) · 28-41

DOI: 10.2174/1874473711104010028 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Drug Abuse Reviewse, erschienen am 01.03.2011. Verfasst von Michael A Yokell und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, The Miriam Hospital, Providence, RI 02906, USA. Hauptthemen laut MEDLINE: Illicit Drugs. Die Arbeit wurde bisher 200-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, NIAID NIH HHS, NCIPC CDC HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The diversion, misuse, and non-medically supervised use of buprenorphine and buprenorphine/naloxone by opioid users are reviewed. Buprenorphine and buprenorphine/naloxone are used globally as opioid analgesics and in the treatment of opioid dependency. Diversion of buprenorphine and buprenorphine/naloxone represents a complex medical and social issue, and has been widely documented in various geographical regions throughout the world. We first discuss the clinical properties of buprenorphine and its abuse potential. Second, we discuss its diversion and illicit use on an international level, as well as motivations for those activities. Third, we examine the medical risks and benefits of buprenorphine's non-medically supervised use and misuse. These risks and benefits include the effect of buprenorphine's use on HIV risk and the risk of its concomitant use with other medications and drugs of abuse. Finally, we discuss the implications of diversion, misuse, and non-medically supervised use (including potential measures to address issues of diversion); and potential areas for further research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Illicit DrugsBuprenorphineDrug OverdoseHIV InfectionsHumansMotivationNaloxoneNarcotic AntagonistsNarcoticsOpioid-Related DisordersRisk-Taking

Substanzen

Illicit DrugsNarcotic AntagonistsNarcoticsNaloxoneBuprenorphine

Autor:innen und Institutionen

  • Division of Infectious Diseases, The Miriam Hospital, Providence, RI 02906, USA.

Förderung

  • NIDA NIH HHS
  • NIAID NIH HHS
  • NCIPC CDC HHS

Zitieren

APA

Yokell, M. A., Zaller, N. D., Green, T. C., & Rich, J. D. (2011). Buprenorphine and Buprenorphine/Naloxone Diversion, Misuse, and Illicit Use: An International Review. Current Drug Abuse Reviewse, 4(1), 28-41. https://doi.org/10.2174/1874473711104010028

Vancouver

Yokell MA, Zaller ND, Green TC, Rich JD. Buprenorphine and Buprenorphine/Naloxone Diversion, Misuse, and Illicit Use: An International Review. Current Drug Abuse Reviewse. 2011;4(1):28-41. doi:10.2174/1874473711104010028

BibTeX
@article{Yokell2011,
  author = {Yokell, Michael A and Zaller, Nickolas D and Green, Traci C and Rich, Josiah D},
  title = {Buprenorphine and Buprenorphine/Naloxone Diversion, Misuse, and Illicit Use: An International Review},
  journal = {Current Drug Abuse Reviewse},
  year = {2011},
  volume = {4},
  number = {1},
  pages = {28--41},
  doi = {10.2174/1874473711104010028}
}
Kostenlos starten →